In this review, we examined the role of phagocytic cell death in gliomas and strategies to modulate the balance between “don’t-eat-me” CD47/SIRPα and “eat-me” CALR/STC1 axes for therapeutic benefits. This evidence concerns the gene STC1 and glioma.